收回:由免疫检查点抑制剂和抗TIGIT治疗诱导的急性乙酸性肺炎
Asna Mohammed1, Bo Tang2, Sean Sadikot2
1Department of Medicine, Hackensack University Medical Center, Hackensack, NJ, USA.
The American journal of case reports
|July 30, 2024
概括
由于未经授权使用材料或数据,该研究已被撤回. 最初的研究涉及免疫检查点抑制剂和抗TIGIT治疗.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 和抗TIGIT疗法是新的癌症治疗方法.
- 急性乙性肺炎 (AEP) 是一种与某些药物相关的罕见不良事件.
- AEP与ICI和抗TIGIT联合治疗之间的特定关联需要进一步研究.
研究的目的:
- 报告一种急性乙酸性肺炎病例.
- 调查AEP与使用免疫检查点抑制剂和抗TIGIT治疗之间的潜在联系.
主要方法:
- 病例报告详细介绍了临床表现,诊断工作和治疗.
- 对药物诱导的肺损伤相关文献的审查.
主要成果:
- 患者在接受ICI和抗TIGIT治疗后发展出AEP.
- 组织病理学发现与埃索诺菲尔透到肺部是一致的.
结论:
- 急性乙性肺炎是联合免疫检查点抑制剂和抗TIGIT治疗的潜在不良事件.
- 临床医生应对接受这些治疗的患者的呼吸系统症状保持警.
- 需要进一步的研究来了解AEP在这种情况下的机制和发病率.
相关概念视频
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...


